Dramatic Response to Ustekinumab Treatment in a Patient with Ankylosing Spondylitis and Crohn’s Disease and Anti-tumor Necrosis Factor-alpha Drug Induced Psoriasis

Journal Title: Turkish Journal of Osteoporosis - Year 2020, Vol 26, Issue 3

Abstract

Treatment with anti-tumour necrosis factor-alpha (anti-TNF-α) drugs provides significant improvements in many chronic inflammatory diseases with common pathogenesis, including Crohn’s disease, ankylosing spondylitis and psoriasis. However, during these treatments, paradoxically, cutaneous side effects such as psoriasis can be seen. Although its pathophysiology is well understood, it is thought that TNF-α blockade triggers locally excessive interferon-α production in predisposed subjects and causes psoriatic lesions. In this case report, we present a 50-year-old female patient with ankylosing spondylitis and Crohn’s disease who used adalimumab and then infliximab and developed psoriasiform lesions due to these drugs. Anti-TNF-α treatment was discontinued, and ustekinumab was started. Psoriasiform rashes improved; disease activity of ankylosing spondylitis and Crohn’s disease was suppressed. Ustekinumab may be a good option to manage ankylosing spondylitis and patients with Crohn’s disease who develop psoriasiform rashes due to anti-TNF-α drugs.

Authors and Affiliations

Sevilay Kılıç, Hatice Reşorlu, Alper Ekinci, Ayşe Selcen Bulut Keskin

Keywords

Related Articles

The Level of Osteoporosis Knowledge and the Related Factors Among Women Who Attended İskenderun Public Education Center Courses

Objective: This study aimed to evaluate the levels of osteoporosis knowledge and self-efficacy and the related factors. Materials and Methods: The study was conducted with 419 women aged between 19 and 60 years who atte...

Evaluation of Osteoporosis Awareness in Chronic Obstructive Pulmonary Disease Patients

Objective: Osteoporosis is a significant health problem that affects the quality of life negatively and places a serious burden on the national economy. The risk of osteoporosis in chronic obstructive pulmonary disease (...

Serum Melatonin Levels in Patients with Behçet’s Disease

Objective: Melatonin (MLT) hormone has been reported to play a role in the immunopathogenesis and aetiology of many chronic inflammatory diseases. We aimed to investigate the role of MLT in Behçet’s disease (BD) by deter...

Benefits, Treatment Compliance, Awareness and Expectation Levels Related to Treatment of Patients Taking Physical Therapy Program

Objective: In our study, we aimed to determine the expectations, treatment compliance, benefit status, and satisfaction levels of patients who had applied physical therapy (PT) outpatient clinic in our hospital. Materia...

Download PDF file
  • EP ID EP691613
  • DOI 10.4274/tod.galenos.2020.71677
  • Views 106
  • Downloads 0

How To Cite

Sevilay Kılıç, Hatice Reşorlu, Alper Ekinci, Ayşe Selcen Bulut Keskin (2020). Dramatic Response to Ustekinumab Treatment in a Patient with Ankylosing Spondylitis and Crohn’s Disease and Anti-tumor Necrosis Factor-alpha Drug Induced Psoriasis. Turkish Journal of Osteoporosis, 26(3), -. https://europub.co.uk/articles/-A-691613